RAC 0.65% $1.56 race oncology ltd

Ann: Bisantrene shows potent anticancer activity in AML models, page-90

  1. 2,779 Posts.
    lightbulb Created with Sketch. 2851
    how long before we see anything eventuate? As Index mentioned consensus will take time.

    What is a deal worth? Please check the billion+ term sheet is USD and not JPY.

    The biggest question, is Astex the right fit or just convenient due to legacy dealings / drug supply agreement?

    Decitabine is not really cardiotoxic so only DACS potential. AML trial / licensing would be a start is this just the incentive to kickstart that? Realistically are we 5 years away minimum for any DACS trials?

    CPACS v DACS and impact on RC220 pricing.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.56
Change
0.010(0.65%)
Mkt cap ! $265.8M
Open High Low Value Volume
$1.55 $1.56 $1.51 $95.69K 62.25K

Buyers (Bids)

No. Vol. Price($)
2 3015 $1.55
 

Sellers (Offers)

Price($) Vol. No.
$1.56 4018 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.